RESEARCH INST NATIONWIDE CHILDREN'S HOSP
A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2)
A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) is a funding opportunity from RESEARCH INST NATIONWIDE CHILDREN'S HOSP, up to 593214, closing February 28, 2027.
Feb 28, 2027
(212d left)Overview
PROJECT SUMMARY We developed a tissue engineered vascular graft (TEVG) designed specifically for use in congenital heart surgery. The TEVG is made by seeding autologous bone marrow-derived mononuclear cells onto a biodegradable tubular scaffold. Once implanted the scaffold degrades and the TEVG transforms into a…